Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-02-28Clinical Trial Update: Continuation Study of Lapatinib Monotherapy or Lapatinib in Combination With Other Anti-cancer Agents [Phase 1]
This source documents a completed Phase 1 continuation study of lapatinib as monotherapy or in combination with other anti-cancer agents for…
-
CLINICAL_TRIALS trial_result · 2018-02-28Clinical Trial Update: Understanding the Value of Community Vital Signs in Primary Care
This clinical trial update reports the completion of NCT02512835, a study evaluating the value of incorporating community vital signs into p…
-
CLINICAL_TRIALS trial_result · 2018-02-28Clinical Trial Update: Intrathecal Pertuzumab and Trastuzumab in Patients With New Untreated Asymptomatic or Low Symptomatic Brain Metastasis in HER2 Positive Breast Cancer [Phase 1]
Clinical trial update for intrathecal pertuzumab and trastuzumab in HER2-positive breast cancer with brain metastases; this Phase 1 study ha…
-
CLINICAL_TRIALS trial_result · 2018-02-28Clinical Trial Update: Assessing Treatment Response in Breast Cancer With Functional Imaging
A completed clinical trial evaluating the use of functional imaging to assess treatment response in breast cancer.
-
CLINICAL_TRIALS trial_result · 2018-02-28Clinical Trial Update: Using Bio Markers to Predict Disease Recurrence and Cognitive Function in High Risk Breast Ca
This ClinicalTrials.gov study investigates whether biomarkers can predict disease recurrence and cognitive function in high-risk breast canc…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-02-26Clinical Trial Update: Study Of Ispinesib In Subjects With Breast Cancer [Phase 2]
A Phase 2 clinical trial update reports the results of ispinesib in subjects with breast cancer. The study has completed and results were po…
-
CLINICAL_TRIALS trial_result · 2018-02-26Clinical Trial Update: A Prototype Tri-modal Imaging Device for Breast Cancer [Phase 1]
A Phase 1 trial evaluating a prototype tri-modal imaging device for breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2018-02-23Clinical Trial Update: A Phase II, Dose-finding Study of F-627 in Patients With Breast Cancer Receiving Myelotoxic Chemotherapy. [Phase 2]
Phase II dose-finding study of F-627 in breast cancer patients receiving myelotoxic chemotherapy has completed.
-
CLINICAL_TRIALS trial_result · 2018-02-23Clinical Trial Update: Randomized Clinical Trial Evaluating the Use of the Laser-Assisted Immunotherapy (LIT/inCVAX) in Advanced Breast Cancer [Phase 3]
Phase 3 randomized trial evaluating Laser-Assisted Immunotherapy (LIT/inCVAX) in advanced breast cancer was terminated; no further results r…
-
CLINICAL_TRIALS trial_result · 2018-02-23Clinical Trial Update: Neoadjuvant Goserelin for Triple Negative Breast Cancer [Phase 2]
Phase 2 trial update on neoadjuvant goserelin for triple-negative breast cancer is reported, status and results are not specified.
-
CLINICAL_TRIALS trial_result · 2018-02-23Clinical Trial Update: Interhospital Variability in Programmes to Prevent Axillary Lymphadenectomy Sequels in Breast Cancer Patients.
This clinical trial update discusses interhospital variability in programs designed to prevent axillary lymphadenectomy sequelae in breast c…
-
CLINICAL_TRIALS trial_result · 2018-02-20Clinical Trial Update: The Use of 18F-ALF-NOTA-PRGD2 PET/CT Scan to Predict the Efficacy and Adverse Events of Apatinib in Malignancies. [Phase 4]
Phase 4 clinical trial evaluating whether a PET/CT imaging agent (18F-ALF-NOTA-PRGD2) can predict efficacy and adverse events of apatinib in…
-
CLINICAL_TRIALS trial_result · 2018-02-15Clinical Trial Update: Intraoperative Radiotherapy for Korean Patients With Breast Cancer [Phase 2]
Phase 2 clinical trial update on intraoperative radiotherapy for breast cancer in Korean patients.
-
CLINICAL_TRIALS trial_result · 2018-02-15Clinical Trial Update: Neoadjuvant Trastuzumab and Letrozole for Postmenopausal Women [Phase 2]
Phase 2 clinical trial update evaluating neoadjuvant trastuzumab and letrozole in postmenopausal women with breast cancer.
-
CLINICAL_TRIALS trial_result · 2018-02-09Clinical Trial Update: Vitamin D3 for Aromatase Inhibitor Induced Arthralgias [Phase 2]
Phase 2 trial evaluating vitamin D3 for arthralgia associated with aromatase inhibitor therapy in breast cancer patients; study completed wi…
-
CLINICAL_TRIALS trial_result · 2018-02-06Clinical Trial Update: Efficacy and Safety Study of Enzalutamide in Combination With Exemestane in Patients With Advanced Breast Cancer [Phase 2]
Pfizer reported Phase 2 trial results evaluating the combination of enzalutamide and exemestane in advanced breast cancer, focusing on effic…
-
CLINICAL_TRIALS trial_result · 2018-02-06Clinical Trial Update: The Maintenance Regimen and Revised Regimen for Advanced Breast Cancer Survivors After First-line Salvage Therapy [Phase 2, Phase 3]
A Phase 2/Phase 3 trial update evaluating maintenance and revised regimens for advanced breast cancer survivors after first-line salvage the…
-
CLINICAL_TRIALS trial_result · 2018-02-05Clinical Trial Update: Carvedilol Effect in Preventing Chemotherapy - Induced Cardiotoxicity [Phase 3]
Phase 3 trial evaluating carvedilol to prevent chemotherapy-induced cardiotoxicity in patients with breast cancer and heart failure.
-
CLINICAL_TRIALS trial_result · 2018-02-01Clinical Trial Update: Neoadjuvant Propanolol in Breast Cancer [Phase 2]
A Phase 2 neoadjuvant trial of propranolol in breast cancer was terminated; results were posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-02-01Clinical Trial Update: A Study to Examine the Effects of an Experimental Drug on Women With Breast Cancer and Metastatic Bone Disease (MBD)(0822-016)(COMPLETED) [Phase 2]
Phase 2 trial evaluating an experimental drug in women with breast cancer and metastatic bone disease has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-01-30Clinical Trial Update: Pyrotinib in Metastatic HER2 Non-amplified But HER2 Mutant Breast Cancer [Phase 2]
Phase 2 trial update for pyrotinib in metastatic HER2 non-amplified but HER2-mutant breast cancer.
-
CLINICAL_TRIALS trial_result · 2018-01-30Clinical Trial Update: A Neoadjuvant Study of Abemaciclib (LY2835219) in Postmenopausal Women With Hormone Receptor Positive, HER2 Negative Breast Cancer [Phase 2]
A Phase 2 neoadjuvant trial evaluated abemaciclib (LY2835219) in postmenopausal women with hormone receptor-positive, HER2-negative breast c…
-
CLINICAL_TRIALS trial_result · 2018-01-25Clinical Trial Update: Use of the Contura™ Catheter in Intermediate-Risk, Pathological Stage 0, I, or II (Up to 3.0 cm) Breast Cancer Patients [Phase 4]
Phase 4 clinical trial update evaluating Contura Catheter in intermediate-risk, early-stage breast cancer patients.
-
CLINICAL_TRIALS trial_result · 2018-01-25Clinical Trial Update: Use of the Contura™ Catheter to Deliver Accelerated Partial Breast Irradiation to "Low-risk" Breast Cancer Patients [Phase 4]
Phase 4 trial update on using the Contura catheter for accelerated partial breast irradiation in low-risk breast cancer patients.
-
CLINICAL_TRIALS trial_result · 2018-01-23Clinical Trial Update: A Study Of PF-05280014 [Trastuzumab-Pfizer] Or Herceptin® [Trastuzumab-EU] Plus Paclitaxel In HER2 Positive First Line Metastatic Breast Cancer Treatment (REFLECTIONS B327-02) [Phase 3]
Phase 3 trial evaluating PF-05280014 (trastuzumab-Pfizer) or trastuzumab-EU with paclitaxel for first-line HER2-positive metastatic breast c…